Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Cancer Biopsy market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Cancer Biopsy market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
The Cancer Biopsy market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Cancer Biopsy products across developed and developing countries of the world.
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Cancer Biopsy products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Cancer Biopsy market.
To learn more about this report
Increasing research and development spending on Cancer Biopsy development has been the leading industry trend of Cancer Biopsy market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
To learn more about this report
| Report Attributes | Details |
| The market size value in 2021 | USD XX.XX Million |
| CAGR (2021 - 2028) | XX.XX % |
| The Revenue forecast in 2028 | USD XX.XX Million |
| Base year for estimation | 2021 |
| Historical data | 2018-2019 |
| Forecast period | 2022-2028 |
| Quantitative units |
|
| Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered | By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook | Tissue Biopsies, Liquid Biopsies, Others |
| By Application Outlook | Breast Cancer, Colorectal Cancer, Cervical Cancers, Lung Cancers, Prostate Cancers, Skin Cancers, Blood Cancers, Kidney Cancers, Others |
| Regional scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope | U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled | QIAGEN; Illumina Inc.; ANGLE plc.; BD; Myriad Genetics; Hologic, Inc.; BIOCEPT, INC.; Thermo Fisher Scientific, Inc.; Danaher Corporation; F. Hoffmann-La Roche Ltd.; Epigenomics AG; HelioHealth (Laboratory for Advanced Medicine); 20/20 Genesystems, Inc. (Genesys Biolabs); Personal Genome Diagnostics, Inc.; Natera, Inc.; Chronix Biomedical, Inc.; Personalis, Inc.; Lucence Health, Inc.; Freenome Holdings, Inc.; Grail, INC.; Guardant Health; Exact Sciences Corporation; Biodesix (Integrated Diagnostics); Oncimmune |
| Customization Available | Yes, the report can be tailored to meet your specific requirements. |
1 Methodology and Scope
1.1 Market segmentation & scope
1.2 Information Procurement
1.2.1 Purchased Database
1.2.2 Eternity’s Internal Database
1.2.3 Secondary sources & third-party perspectives
1.2.4 Primary Research
1.3 Information analysis
1.4 Market formulation & data visualization
1.5 Data validation & publishing
2 Executive Summary
3 Cancer Biopsy Market Variables, Trends & Scope
3.1 Market Dynamics
3.1.1 Market Driver Analysis
3.1.2 Market Restraints
3.1.3 Market Challenge Analysis
3.1.4 Market Opportunities
3.1.5 Micro & Macro Indicator
3.2 Impact of COVID-19 Pandemic on Global Cancer Biopsy Market
3.2.1 Overview of Changing Landscape
3.2.2 Pre-covid & Post-Covid Market Analysis
3.3 Market Attractiveness Analysis
3.4 Regulatory Scenario
3.5 Industry Trend Analysis- Historic and Future Trend Assessment
3.6 Merger & Acquisition
3.7 New System Launch/Approvals
3.8 Market Analysis Tools
3.8.1 Porter’s Five Forces
3.8.2 PEST Analysis
3.8.3 Value Chain Analysis
3.9 Key Company Ranking Analysis, 2020
4 Global Cancer Biopsy Market Analysis and Forecast, By Type
4.1 Overview & Definition
4.2 Key Trends
4.3 Global Cancer Biopsy Market Value (US$ Mn) Forecast, by Type (2019 – 2028)
4.2.1 Tissue Biopsies
4.2.2 Liquid Biopsies
4.2.3 Others
4.4 Type Comparison Matrix
4.5 Global Cancer Biopsy Market Attractiveness, By Type
5 Global Cancer Biopsy Market Analysis and Forecast, By Application
5.1 Overview & Definition
5.2 Key Trends
5.3 Global Cancer Biopsy Market Value (US$ Mn) Forecast, by Application (2019 – 2028)
5.3.1 Breast Cancer
5.3.2 Colorectal Cancer
5.3.3 Cervical Cancers
5.3.4 Lung Cancers
5.3.5 Prostate Cancers
5.3.6 Skin Cancers
5.3.7 Blood Cancers
5.3.8 Kidney Cancers
5.3.9 Others
5.4 Application Comparison Matrix
5.5 Global Cancer Biopsy Market Attractiveness, by Application
6 Global Cancer Biopsy Market Analysis and Forecast, By Region
6.1 Overview & Definition
6.2 Key Trends
6.3 Global Cancer Biopsy Market Value (US$ Mn) Forecast, by Region (2019 – 2028)
6.4 North America
6.5 Europe
6.6 Asia Pacific
6.7 Latin America
6.8 Middle East & Africa
7 Global Cancer Biopsy Market Attractiveness, by Region
8 North America Cancer Biopsy Market Analysis and Forecast
8.1 Key Findings
8.2 North America Cancer Biopsy Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
8.2.1 Tissue Biopsies
8.2.2 Liquid Biopsies
8.2.3 Others
8.3 North America Cancer Biopsy Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
8.3.1 Breast Cancer
8.3.2 Colorectal Cancer
8.3.3 Cervical Cancers
8.3.4 Lung Cancers
8.3.5 Prostate Cancers
8.3.6 Skin Cancers
8.3.7 Blood Cancers
8.3.8 Kidney Cancers
8.3.9 Others
8.4 North America Cancer Biopsy Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
8.4.1 U.S.
8.4.2 Canada
8.4.3 Rest of North America
8.5 North America Cancer Biopsy Market Attractiveness Analysis
8.5.1 By Type
8.5.2 By Application
8.5.3 By Country
9 Europe Cancer Biopsy Market Analysis and Forecast
9.1 Key Findings
9.2 Europe Cancer Biopsy Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
9.2.1 Tissue Biopsies
9.2.2 Liquid Biopsies
9.2.3 Others
9.3 Europe Cancer Biopsy Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
9.3.1 Breast Cancer
9.3.2 Colorectal Cancer
9.3.3 Cervical Cancers
9.3.4 Lung Cancers
9.3.5 Prostate Cancers
9.3.6 Skin Cancers
9.3.7 Blood Cancers
9.3.8 Kidney Cancers
9.3.9 Others
9.4 Europe Cancer Biopsy Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
9.4.1 U.K.
9.4.2 Germany
9.4.3 France
9.4.4 Italy
9.4.5 Rest of Europe
9.5 Europe Cancer Biopsy Market Attractiveness Analysis
9.5.1 By Type
9.5.2 By Application
9.5.3 By Country
10 Asia Pacific Cancer Biopsy Market Analysis and Forecast
10.1 Key Findings
10.2 Asia Pacific Cancer Biopsy Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
10.2.1 Tissue Biopsies
10.2.2 Liquid Biopsies
10.2.3 Others
10.3 Asia Pacific Cancer Biopsy Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
10.3.1 Breast Cancer
10.3.2 Colorectal Cancer
10.3.3 Cervical Cancers
10.3.4 Lung Cancers
10.3.5 Prostate Cancers
10.3.6 Skin Cancers
10.3.7 Blood Cancers
10.3.8 Kidney Cancers
10.3.9 Others
10.4 Asia Pacific Cancer Biopsy Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
10.4.1 China
10.4.2 India
10.4.3 Japan
10.4.4 South Korea
10.4.5 Rest of APAC
10.5 Asia Pacific Cancer Biopsy Market Attractiveness Analysis
10.5.1 By Type
10.5.2 By Application
10.5.3 By Country
11 Latin America Cancer Biopsy Market Analysis and Forecast
11.1 Key Findings
11.2 Latin America Cancer Biopsy Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
11.2.1 Tissue Biopsies
11.2.2 Liquid Biopsies
11.2.3 Others
11.3 Latin America Cancer Biopsy Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
11.3.1 Breast Cancer
11.3.2 Colorectal Cancer
11.3.3 Cervical Cancers
11.3.4 Lung Cancers
11.3.5 Prostate Cancers
11.3.6 Skin Cancers
11.3.7 Blood Cancers
11.3.8 Kidney Cancers
11.3.9 Others
11.4 Latin America Cancer Biopsy Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
11.4.1 Brazil
11.4.2 Rest of Latin America China
11.5 Latin America Cancer Biopsy Market Attractiveness Analysis
11.5.1 By Type
11.5.2 By Application
11.5.3 By Country
12 Middle East & Africa (MEA) Cancer Biopsy Market Analysis and Forecast
12.1 Key Findings
12.2 Middle East & Africa (MEA) Cancer Biopsy Market Analysis (US$ Mn) and Forecast, By Product Type (2019-2028)
12.2.1 Tissue Biopsies
12.2.2 Liquid Biopsies
12.2.3 Others
12.3 Middle East & Africa (MEA) Cancer Biopsy Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
12.3.1 Breast Cancer
12.3.2 Colorectal Cancer
12.3.3 Cervical Cancers
12.3.4 Lung Cancers
12.3.5 Prostate Cancers
12.3.6 Skin Cancers
12.3.7 Blood Cancers
12.3.8 Kidney Cancers
12.3.9 Others
12.4 Middle East & Africa (MEA) Cancer Biopsy Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
12.4.1 GCC Countries
12.4.2 South Africa
12.4.3 Rest of MEA
12.5 Middle East & Africa (MEA) Cancer Biopsy Market Attractiveness Analysis
12.5.1 By Type
12.5.2 By Application
12.5.3 By Country
13 Competitive Landscape
13.1 Market Players – Competition Matrix
13.2 Market Share Analysis by Key Players, 2020 (%)
13.3 Company Profiles
13.3.1 QIAGEN; Illumina Inc.; ANGLE plc.; BD; Myriad Genetics; Hologic
13.3.1.1 Company Overview
13.3.1.2 Company Snapshot
13.3.1.3 Financial Overview
13.3.1.4 Product Portfolio
13.3.1.5 Key Developments/Strategies
13.3.2 Inc.; BIOCEPT
13.3.3 INC.; Thermo Fisher Scientific
13.3.4 Inc.; Danaher Corporation; F. Hoffmann-La Roche Ltd.; Epigenomics AG; HelioHealth (Laboratory for Advanced Medicine); 20/20 Genesystems
13.3.5 Inc. (Genesys Biolabs); Personal Genome Diagnostics
13.3.6 Inc.; Natera
13.3.7 Inc.; Chronix Biomedical
13.3.8 Inc.; Personalis
13.3.9 Inc.; Lucence Health
13.3.10 Inc.; Freenome Holdings
13.3.11 Inc.; Grail
13.3.12 INC.; Guardant Health; Exact Sciences Corporation; Biodesix (Integrated Diagnostics); Oncimmune
14 Key Takeaways
Choose License Type